Prudential Financial’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $177K | Buy |
34,830
+14,440
| +71% | +$73.4K | ﹤0.01% | 2231 |
|
|
2025
Q1 | $84.2K | Sell |
20,390
-11,310
| -36% | -$46.7K | ﹤0.01% | 2149 |
|
|
2024
Q4 | $235K | Buy |
31,700
+14,452
| +84% | +$107K | ﹤0.01% | 2052 |
|
|
2024
Q3 | $162K | Sell |
17,248
-54,162
| -76% | -$509K | ﹤0.01% | 2537 |
|
|
2024
Q2 | $573K | Sell |
71,410
-4,153
| -5% | -$33.3K | ﹤0.01% | 2110 |
|
|
2024
Q1 | $1.12M | Buy |
75,563
+60,668
| +407% | +$899K | ﹤0.01% | 1761 |
|
|
2023
Q4 | $121K | Buy |
14,895
+704
| +5% | +$5.72K | ﹤0.01% | 2489 |
|
|
2023
Q3 | $64.6K | Buy |
14,191
+974
| +7% | +$4.43K | ﹤0.01% | 2480 |
|
|
2023
Q2 | $93K | Buy |
13,217
+2,906
| +28% | +$20.5K | ﹤0.01% | 2488 |
|
|
2023
Q1 | $63K | Sell |
10,311
-247
| -2% | -$1.51K | ﹤0.01% | 2481 |
|
|
2022
Q4 | $67.5K | Buy |
10,558
+214
| +2% | +$1.37K | ﹤0.01% | 2474 |
|
|
2022
Q3 | $99K | Sell |
10,344
-1,019
| -9% | -$9.75K | ﹤0.01% | 2514 |
|
|
2022
Q2 | $123K | Buy |
+11,363
| New | +$123K | ﹤0.01% | 2512 |
|
|
2021
Q1 | – | Sell |
-39,945
| Closed | -$1.85M | – | 2514 |
|
|
2020
Q4 | $1.85M | Buy |
+39,945
| New | +$1.85M | ﹤0.01% | 1450 |
|
|
2020
Q2 | – | Sell |
-7,714
| Closed | -$231K | – | 2430 |
|
|
2020
Q1 | $231K | Sell |
7,714
-658
| -8% | -$19.7K | ﹤0.01% | 2146 |
|
|
2019
Q4 | $232K | Buy |
+8,372
| New | +$232K | ﹤0.01% | 2291 |
|
|
2019
Q3 | – | Sell |
-8,640
| Closed | -$212K | – | 2442 |
|
|
2019
Q2 | $212K | Buy |
+8,640
| New | +$212K | ﹤0.01% | 2322 |
|